Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Ardent Health, Inc. (ARDT : NYSE)
 
 • Company Description   
Ardent Health Partners Inc. is a provider of healthcare. Ardent Health Partners Inc., formerly known as ARDENT HEALTH, is based in BRENTWOOD, Tenn.

Number of Employees: 24,900

 
 • Price / Volume Information   
Yesterday's Closing Price: $14.17 Daily Weekly Monthly
20 Day Moving Average: 299,335 shares
Shares Outstanding: 143.04 (millions)
Market Capitalization: $2,026.93 (millions)
Beta:
52 Week High: $20.72
52 Week Low: $11.31
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 7.76% 2.89%
12 Week 13.27% -4.41%
Year To Date -17.04% -22.05%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
340 SEVEN SPRINGS WAY SUITE 100
-
BRENTWOOD,TN 37027
USA		 ph: 615-296-3000
fax: -		 investor.relations@ardenthealth.com http://www.ardenthealth.com
 
 • General Corporate Information   
Officers
Martin J. Bonick - President and Chief Executive Officer; Director
Alfred Lumsdaine - Chief Financial Officer
David Byers - Senior Vice President; Chief Accounting Officer
Mark Sotir - Director
Peter Bulgarelli - Director

Peer Information
Ardent Health, Inc. (CHCR)
Ardent Health, Inc. (ESRX)
Ardent Health, Inc. (MYDP)
Ardent Health, Inc. (COR)
Ardent Health, Inc. (GBCS)
Ardent Health, Inc. (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 03980N107
SIC: 8062
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/13/25
Share - Related Items
Shares Outstanding: 143.04
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $2,026.93 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.52 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $1.92 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 5.74% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/13/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 7.36
Trailing 12 Months: 8.64
PEG Ratio: 1.28
Price Ratios
Price/Book: 1.29
Price/Cash Flow: 5.59
Price / Sales: 0.34
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -64.20%
Sales Growth
vs. Year Ago Period: 4.04%
vs. Previous Quarter: -6.79%
ROE
06/30/25 - -
03/31/25 - 16.07
12/31/24 - 22.70
ROA
06/30/25 - -
03/31/25 - 4.69
12/31/24 - 6.42
Current Ratio
06/30/25 - -
03/31/25 - 2.12
12/31/24 - 1.94
Quick Ratio
06/30/25 - -
03/31/25 - 1.98
12/31/24 - 1.82
Operating Margin
06/30/25 - -
03/31/25 - 3.75
12/31/24 - 3.87
Net Margin
06/30/25 - -
03/31/25 - 3.73
12/31/24 - 3.53
Pre-Tax Margin
06/30/25 - -
03/31/25 - 6.32
12/31/24 - 6.09
Book Value
06/30/25 - -
03/31/25 - 10.96
12/31/24 - 10.66
Inventory Turnover
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.00
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.70
12/31/24 - 0.71
Debt-to-Capital
06/30/25 - -
03/31/25 - 41.07
12/31/24 - 41.68
 

Powered by Zacks Investment Research ©